--- title: "Novavax Inc. Stock Underperforms Friday When Compared To Competitors" type: "News" locale: "en" url: "https://longbridge.com/en/news/295979341.md" description: "Novavax Inc. (NVAX) shares fell 1.11% to $8.05 on Friday, underperforming competitors like Johnson & Johnson, Pfizer, and Merck during a broader market decline. The drop ended a three-day winning streak, with the stock trading 32.75% below its 52-week high of $11.97. Trading volume was notably lower than the 50-day average." datetime: "2026-08-14T21:29:11.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295979341.md) - [en](https://longbridge.com/en/news/295979341.md) - [zh-HK](https://longbridge.com/zh-HK/news/295979341.md) generator: "portal-rs" --- # Novavax Inc. Stock Underperforms Friday When Compared To Competitors This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Novavax Inc. (NVAX) slid 1.11% to $8.05 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.28% to 26,729.16 and Dow Jones Industrial Average falling 0.20% to 53,732.41. The stock's fall snapped a three-day winning streak. Novavax Inc. closed 32.75% below its 52-week high of $11.97, which the company reached on February 26th. The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) fell 0.66% to $260.35, Pfizer Inc. (PFE) fell 0.04% to $26.79, and Merck & Co. Inc. (MRK) rose 0.21% to $135.84. Trading volume (2.3 M) remained 1.5 million below its 50-day average volume of 3.8 M. Data source: Dow Jones Market Data, FactSet. Data compiled August 14, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 08-14-26 1729ET ### Related Stocks - [NVAX.US](https://longbridge.com/en/quote/NVAX.US.md) - [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md) - [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md) - [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md) - [PFE.US](https://longbridge.com/en/quote/PFE.US.md) - [MRK.US](https://longbridge.com/en/quote/MRK.US.md) ## Related News & Research - [Novavax to Participate in September Investor Conferences | NVAX Stock News](https://longbridge.com/en/news/297830700.md) - [Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot](https://longbridge.com/en/news/298630872.md) - [Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor Conference](https://longbridge.com/en/news/298539070.md) - [Move aside, Pfizer: This stock is the smarter dividend buy right now](https://longbridge.com/en/news/298353320.md) - [AVAX crypto eyes $8.65 – But first, Avalanche must hold THIS support](https://longbridge.com/en/news/298177979.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**